Alzheimer's disease drug development pipeline: 2017

Cummings, Jeffrey, Lee, Garam, Mortsdorf, Travis, Ritter, Aaron, Zhong, Kate·2017·Alzheimer's & Dementia: Translational Research & Clinical Interventions

DOI 10.1016/j.trci.2017.05.002

Cited by (556)

Items 201–300 of 556

Unraveling the Neuroprotective Effect of Tinospora cordifolia in a Parkinsonian Mouse Model through the Proteomics Approach
Hareram Birla, Chetan Keswani, Saumitra Sen Singh, Walia Zahra, Hagera Dilnashin, Aaina Singh Rathore, Richa Singh, Monika Rajput, Priyanka Keshri, Surya Pratap Singh · 2021 · ACS Chemical Neuroscience
A Quantitative and Narrative Evaluation of Goodman and Gilman’s Pharmacological Basis of Therapeutics
Brian J. Piper, Alexandria A. Alinea, John R. Wroblewski, Sara M. Graham, Daniel Y. Chung, Livia R. M. McCutcheon, Melissa Birkett, Steven S. Kheloussi, Vicky Shah, John L. Szarek et al. · 2019 · Pharmacy
Lack of Benefit With Idalopirdine for Alzheimer Disease
David Alan Bennett · 2018 · JAMA
Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment
Ashleigh C. Duthie, Lidy van Aalten, C. F. Macdonald, Alison D. McNeilly, Jennifer Elizabeth Gallagher, John Richard Geddes, Simon Lovestone, Calum D. Sutherland · 2019 · Frontiers in Molecular Neuroscience
Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats
Adel A. Gomaa, Rania M. Makboul, Mohamed A. El‐Mokhtar, Engy A. Abdel‐Rahman, Esraa A. Ahmed, Mariam A. Nicola · 2020 · Fundamental and Clinical Pharmacology
Current Strategies and Novel Drug Approaches for Alzheimer Disease
Roma Ghai, Kandasamy Nagarajan, Meenakshi Arora, Parul Grover, Nazakat Ali, Garima Talwar Kapoor · 2020 · CNS & Neurological Disorders - Drug Targets
Alzheimer Disease Clinical Trials Targeting Amyloid
Allison Bethanne Reiss, Natalie Montufar, Joshua R. DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Amy D. Glass, Hirra A. Arain, Mark M. Stecker · 2021 · The Neurologist
Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
Aliki Drakontaeidi, Eleni A. Pontiki · 2024 · International Journal of Molecular Sciences
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
Pallavi Duggal, Sidharth Mehan · 2019 · Journal of Alzheimer s Disease Reports
Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
Szu-Ying Lin, Kun‐Ju Lin, Po-Chen Lin, Chin-Chang Huang, Chiung‐Chih Chang, Yi‐Chung Lee, Ing‐Tsung Hsiao, Tzu‐Chen Yen, Wen-Sheng Huang, Bang‐Hung Yang et al. · 2019 · Alzheimer s Research & Therapy
QbD-steered development of mixed nanomicelles of galantamine: Demonstration of enhanced brain uptake, prolonged systemic retention and improved biopharmaceutical attributes
Shikha Lohan, Teenu Sharma, Sumant Saini, Rajan Swami, Dinesh Kumar Dhull, Sarwar Beg, Kaisar Raza, Anil Kumar, Bhupinder Singh · 2021 · International Journal of Pharmaceutics
Potential for prevention of dementia in Denmark
Kasper Jørgensen, T. Rune Nielsen, Ann Nielsen, Gunhild Waldemar · 2023 · Alzheimer s & Dementia
Collagen hydrogel confinement of Amyloid-β (Aβ) accelerates aggregation and reduces cytotoxic effects
Laura W. Simpson, Gregory Lee Szeto, Hacène Boukari, Theresa A. Good, Jennie Baier Leach · 2019 · Acta Biomaterialia
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer’s Disease Spectrum
Noemi Massetti, Mirella Russo, Raffaella Franciotti, Davide Nardini, Giorgio Maria Mandolini, Alberto Granzotto, Manuela Bomba, Stefano Delli Pizzi, Alessandra Mosca, Reinhold Scherer et al. · 2021 · Journal of Alzheimer s Disease
Residents’ satisfaction with sustainable tourism: the moderating role of environmental awareness
Ikram Ullah Khan, Safeer Ullah Khan, Salman Khan · 2022 · Tourism Critiques Practice and Theory
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Karin E. Wahlberg, Bengt G. Winblad, Amanda Cole, William L. Herring, Joakim Ramsberg, Ilona Torontali, Pieter Jelle Visser, Anders B. Wimo, Lieve Wollaert, Linus Jönsson · 2023 · Journal of Internal Medicine
Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center
John Hanfelt, Limin Peng, Felicia C. Goldstein, James J. Lah · 2018 · Neurobiology of Disease
A blood-based signature of cerebrospinal fluid Aβ1–42 status
Benjamin Goudey, Bowen John Fung, Christine Schieber, Noel Garry Faux, Michael Walter Weiner, Paul S. S. Aisen, Ronald Carl Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki et al. · 2019 · Scientific Reports
Alzheimer's Disease and Its Potential Alternative Therapeutics.
Brent R. Kisby, Juliet T. Jarrell, Agar Me, Cohen Ds, Rosin Er, Cahill Cm, Jack T. Rogers, Xudong Huang · 2019 · PubMed
Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Iván Carrera, Olaia Martínez, Ramón Cacabelos · 2019 · Current Topics in Medicinal Chemistry
Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
Jaime R. Cabrera‐Pardo, Jorge Fuentealba, Javiera Gavilán, D. Cajas, José Becerra, Mariola Napiórkowska · 2020 · Frontiers in Pharmacology
The value of supportive care: A systematic review of cost-effectiveness of non-pharmacological interventions for dementia
Angelica Guzzon, Vincenzo Stefano Rebba, Omar Paccagnella, Michela Rigon, Giovanni Boniolo · 2023 · PLoS ONE
How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
Stéphane Epelbaum, Claire Paquet, Jacques Hugon, Julien Dumurgier, David Wallon, Didier Hannequin, Thérèse Jonveaux, Annick Besozzi, Stéphane Pouponneau, Caroline Hommet et al. · 2019 · BMJ Open
Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
Sumner, Isabelle L., Edwards, Ross A., Asuni, Ayodeji A., Teeling, Jessica L. · 2018 · Frontiers in Neuroscience
The proportion of Alzheimer’s disease attributable to apolipoprotein E
Dylan M. Williams, Sami Heikkinen, Mikko O. Hiltunen, FinnGen, Neil M Davies, Emma L. Anderson · 2026 · npj Dementia
The Quest for an Alzheimer Therapy
Stefano Francesco Cappa · 2018 · Frontiers in Neurology
Evaluation of neuroprotective effects of Canna indica L against aluminium chloride induced memory impairment in rats
Ojha, Prachi S., Biradar, Prakash R., Tubachi, Siddarth, Patil, Vishal S. · 2023 · Advances in Traditional Medicine
Synapse vulnerability and resilience across the clinical spectrum of dementias
Raquel N. Taddei, Karen Duff · 2025 · Nature Reviews Neurology
An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products
Zeba Firdaus, Tryambak Deo Singh · 2020 · Mini-Reviews in Medicinal Chemistry
A Real-Time Sensing System for Monitoring Neural Network Degeneration in an Alzheimer’s Disease-on-a-Chip Model
Nien‐Che Liu, Chu-Chun Liang, Yi‐Chen Ethan Li, I‐Chi Lee · 2022 · Pharmaceutics
Photobiomodulation for Hypertension and Alzheimer’s Disease
Audrey Valverde, John Mitrofanis · 2022 · Journal of Alzheimer s Disease
Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer’s Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion
Arthur Esquer, Frédéric Blanc, Nicolas Collongues · 2023 · Neurology and Therapy
A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics
Rosa Purgatorio, Angelina Boccarelli, Leonardo Pisani, Modesto de Candia, Marco Catto, Cosimo Altomare · 2024 · Antioxidants
The clinical importance of suspected non-Alzheimer disease pathophysiology
Stephanie J. B. Vos, Aurore Delvenne, Clifford R. Jack, Dietmar Rudolf Thal, Pieter Jelle Visser · 2024 · Nature Reviews Neurology
Oxymatrine can attenuate pathological deficits of Alzheimer's disease mice through regulation of neuroinflammation
Yun Chen, Ziyou Qi, Baojun Qiao, Zhanyun Lv, Yanlei Hao, Hongfang Li · 2019 · Journal of Neuroimmunology
Challenges in Alzheimer’s Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Conrado, Daniela J., Duvvuri, Sridhar, Geerts, Hugo, Burton, Jackson, Biesdorf, Carla, Ahamadi, Malidi, Macha, Sreeraj, Hather, Gregory, Francisco Morales, Juan, Podichetty, Jagdeep et al. · 2020 · Clinical Pharmacology & Therapeutics
Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer’s Disease
Jeffrey L. Cummings · 2020 · Journal of Neuropsychiatry
Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease
Devashi Paliwal, Tim W. McInerney, Judy Pa, Russell Howard Swerdlow, Simon Easteal, Shea J. Andrews, for the Alzheimer’s Disease Neuroimaging Initiative · 2020 · Neurobiology of Aging
Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer’s disease
Dirong Wu, Jiao Chen, Keke Luo, Hui Li, Ting Liu, Li Li, Zeqin Dai, Yongjun Li, Yong‐Long Zhao, Xiao‐Zhong Fu · 2022 · Bioorganic Chemistry
Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
Heleen M. A. Hendriksen, Aniek M. van Gils, Argonde C. van Harten, Tobias Hartmann, Francesca Mangialasche, Anita Kamondi, Miia Kivipelto, Hanneke F. M. Rhodius‐Meester, Ellen M. A. Smets, Wiesje M. van der Flier et al. · 2023 · Alzheimer s Research & Therapy
Canine cognitive decline and Alzheimer disease: clinical insights to solve a shared one-health problem
Joel Ehrenzweig, Robert Paul Hunter · 2023 · Journal of the American Veterinary Medical Association
Early detection of Alzheimer’s disease using neuropsychological tests: a predict–diagnose approach using neural networks
Devarshi Mukherji, Manibrata Mukherji, Nivedita Mukherji, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Informatics
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
Guoqiao Wang, Lei Liu, Yan Li, Andrew J. Aschenbrenner, Randall John Bateman, Paul Delmar, Lon S. S. Schneider, Richard Kennedy, Gary Cutter, Chengjie Xiong · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Regenerative medicine improve neurodegenerative diseases
Seyedeh Sara Ashraf, Vahid Hosseinpour Sarmadi, Ghazaleh Larijani, Soheila Naderi Gharahgheshlagh, Sara Ramezani, Soraya Moghadamifar, Seyedeh Lena Mohebbi, Peiman Brouki Milan, Seyed Mohammad Amin Haramshahi, Nooshin Ahmadirad et al. · 2022 · Cell and Tissue Banking
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael Thomas Heneka, Christoffer Clemmensen · 2025 · Nature Metabolism
Aggregation Mechanism of Alzheimer’s Amyloid β-Peptide Mediated by α-Strand/α-Sheet Structure
Anand Balupuri, Kwang-Eun Choi, Nam Sook Kang · 2020 · International Journal of Molecular Sciences
A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia
Horia Păunescu, Lorena Dima, Isabel Ghiţă, Laurențiu Coman, Petru Iulian Ifteni, Ion Fulga, Oana Andreia Coman · 2020 · American Journal of Therapeutics
Advances in the treatment and management of frontotemporal dementia
Alberto Benussi, Barbara Borroni · 2023 · Expert Review of Neurotherapeutics
Resting-state electroencephalographic characteristics related to mild cognitive impairments
Seong‐Eun Kim, Chanwoo Shin, Junyeop Yim, Kyoungwon Seo, Hokyoung Blake Ryu, Hojin Choi, Jinseok Park, Byoung‐Kyong Min · 2023 · Frontiers in Psychiatry
Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice
Torsten Hoffmann, Jens‐Ulrich Rahfeld, Mathias Schenk, Falk Ponath, Koki Makioka, Birgit Hutter‐Paier, Inge Lues, Cynthia Ann Lemere, Stephan Schilling · 2021 · International Journal of Molecular Sciences
Recent Advances in Antibody Therapy for Alzheimer’s Disease: Focus on Bispecific Antibodies
Han‐Mo Yang · 2025 · International Journal of Molecular Sciences
Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Jason R. Bock, Junko Hara, Dennis Fortier, Michael David Lee, Ronald Carl Petersen, William Rodman Shankle · 2021 · The Journal of Prevention of Alzheimer s Disease
A method for diagnosis support of mild cognitive impairment through EEG rhythms source location during working memory tasks
Rodrigo San-Martin, Erin K. Johns, Godofredo Quispe Mamani, Guilherme Tavares, Natalie A. Phillips, Francisco J. Fraga · 2021 · Biomedical Signal Processing and Control
From reaction kinetics to dementia: A simple dimer model of Alzheimer’s disease etiology
Michael R. Lindstrom, Manuel B. Chavez, Elijah A. Gross-Sable, Eric Y. Hayden, David B. Teplow · 2021 · PLoS Computational Biology
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol
Salvatore Mazzeo, Michael Lassi, Sonia Padiglioni, Alberto Arturo Vergani, Valentina Moschini, Maenia Scarpino, Giulia Giacomucci, Rachele Burali, Carmen Morinelli, Carlo Fabbiani et al. · 2023 · BMC Neurology
The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
Stephanie Tam, Darcy Wear, Christopher Daniel Morrone, Wai Haung Yu · 2024 · Journal of Neurochemistry
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease‐modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience
Aaron R. Ritter, Jeffrey L. Cummings, Christin Nance, Justin B. Miller · 2018 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Multicrossover Randomized Controlled Trial Designs in A lzheimer Disease
Steven Edward Arnold, Rebecca A. Betensky · 2018 · Annals of Neurology
Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R
Jessica S. Fortin, Kazuma Shimanaka, Akella Prasanth Saraswati, Mengyu Liu, Kuang‐Wei Wang, Hsiao‐Tien Chien Hagar, Soham Maity, Susantha K. Ganegamage, Edmund L. Ellsworth, Scott Counts et al. · 2022 · Journal of Molecular Structure
Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force
Jeffrey L. Cummings, Nick C. Fox, Bruno J. Vellas, Paul S. S Aisen, Guogen Shan · 2018 · The Journal of Prevention of Alzheimer s Disease
Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease
Marieke J. H. J. Dekker, Jacoline C. Bouvy, Diana O'Rourke, Robin Thompson, Amr Makady, Pall F. Jonsson, Christine C. Gispen‐de Wied · 2019 · Frontiers in Medicine
Pharmakologische Therapie der Alzheimer-Demenz
Patrick Müller, Markus Fendt, N. Müller · 2019 · Der Internist
Meroterpenoids with BACE1 Inhibitory Activity from the Fruiting Body of Boletinus asiaticus
Genki Yatsu, Yoshihiro Kino, Hiroaki Sasaki, Jun‐ichi Satoh, Kaoru Kinoshita, Kiyotaka Koyama · 2019 · Journal of Natural Products
Index of ideality of correlation and correlation contradiction index: a confluent perusal on acetylcholinesterase inhibitors
Kiran Bagri, Ashwani Kumar, Manisha Nimbhal, Prof Parvin Kumar · 2020 · Molecular Simulation
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
Benjamin R. Underwood, Ilianna Lourida, Jessica Gong, Stefano Tamburin, Eugene Yee Hing Tang, Emad Sidhom, Xin You Tai, Matthew J. Betts, Janice M. Ranson, Margarita Zachariou et al. · 2025 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Advancements in the treatment of Alzheimer's disease: a comprehensive review
Srushti Rajanna, Prajwal Pradeep Gundale, Apoorva Dev Mahadevaiah · 2025 · Dementia & Neuropsychologia
Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics
Elodie Bosc, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, Kaitao Zhao, Ronak Patel, Eric Duplus et al. · 2022 · Cell Death and Disease
Oral anticoagulants: A plausible new treatment for Alzheimer's disease?
Raquel Toribio‐Fernández, Carlos Cerón, Catarina Tristão‐Pereira, Irene Fernandez‐Nueda, Ana Pérez‐Castillo, José Fernández‐Ferro, María Ángeles Moro, Borja Ibáñez, Valentı́n Fuster, Marta Cortés‐Canteli · 2023 · British Journal of Pharmacology
Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice
Mahvish Faisal, Jana Aid, Nodirov Bekzod Holiqjon o‘g‘li, Benjamin Lee, Miriam Ann Hickey · 2023 · PLoS ONE
Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova, Jianqin Lu · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer’s disease: a randomized controlled trial
Kate E. Hoy, Melanie Emonson, Neil Wayne Bailey, Caitlyn Rogers, Hannah L. Coyle, Freya Stockman, Paul Bernard Fitzgerald · 2023 · Neurobiology of Aging
A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD)
Pinky Gehlot, Rekha Pathak, Sunil Kumar, Naveen Kumar Choudhary, Vivek K. Vyas · 2024 · Bioorganic & Medicinal Chemistry
Population-level pharmacogenomics for precision drug development in dementia
Ramón Cacabelos · 2018 · Expert Review of Precision Medicine and Drug Development
Definition and Quantification of Six Immune- and Neuroregulatory Serum Proteins in Healthy and Demented Elderly
Carola G. Schipke, Oliver L. Gunter, Christina Weinert, Patrick Scotton, Jörg-Peter Sigle, Jim Kallarackal, Dieter Kabelitz, Asmus Finzen, Annegret Feuerhelm · 2019 · Neurodegenerative Disease Management
Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease
Lenka Hromádková, Saak Victor Ovsepian · 2019 · Journal of Immunology Research
Identifying Alzheimer’s disease-related proteins by LRRGD
Tianyi Zhao, Yang Hu, Tianyi Zang, Liang Cheng · 2019 · BMC Bioinformatics
Anacardic Acid Complexes as Possible Agents Against Alzheimer’s Disease Through Their Antioxidant, In vitro, and In silico Anticholinesterase and Ansiolic Actions
Wildson Max Barbosa da Silva, Solange de Oliveira Pinheiro, Daniela Ribeiro Alves, Jane Eire Silva Alencar de Menezes, Francisco Ernani Alves Magalhães, Francisca Crislândia Oliveira Silva, Márcia Machado Marinho, Emmanuel Silva Marinho, Selene Maia de Morais · 2020 · Neurotoxicity Research
The Development of Pharmacological Therapies for Alzheimer’s Disease
Lin Ping, Junyu Sun, Qi Cheng, Yue Yang, Dennis John Cordato, Jianqun Gao · 2021 · Neurology and Therapy
Cerebrospinal fluid from Alzheimer’s disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer’s disease
Jeongmin Lee, Soo Jin Kwon, Jang Hoon Kim, Hyemin Jang, Na Kyung Lee, Jung Won Hwang, Jong Hwa Kim, Jong Wook Chang, Duk Lyul Na · 2019 · Scientific Reports
The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults
Marcela Kitaigorodsky, Elizabeth Crocco, Rosie E. Curiel, Giselle Mirtes Amaral Leal, D. Diane Zheng, Melissa K. Eustache, Maria T. Greig‐Custo, William Barker, Ranjan Duara, David Loewenstein · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Experimental modelling of Alzheimer's disease for therapeutic screening
Laura Blaikie, Graeme Kay, Patrı́cia Maciel, Paul Kong Thoo Lin · 2022 · European Journal of Medicinal Chemistry Reports
Projections of costs and quality adjusted life years lost due to dementia from 2020 to 2050: A population‐based microsimulation study
Chiara C. Brück, Frank J. Wolters, M. Arfan Ikram, Inge M.C.M. de Kok · 2023 · Alzheimer s & Dementia
Ability and Willingness to Participate in Dementia Clinical Research: A Qualitative Study
Nicole Bouranis, Sherril B. Gelmon, Allison Lindauer · 2023 · Patient
Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
Jimin Kim, Hanna Jeon, Hye Yun Kim, Young Soo Kim · 2023 · ChemBioChem
Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer’s Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice
Yang Zhu, Hao Huang, Zhi Chen, Yong Kang Tao, Lingyi Liao, Shi-Hao Gao, Yan‐Jiang Wang, Chang-Yue Gao · 2023 · Neuroscience Bulletin
Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease
Shan He, Junhe Shi, Hua Chai, Lina Ma, Hui Pei, Ping Zhang, Dazhuo Shi, Hao Li · 2024 · Heliyon
Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Zhipei Sang, Jian Shi, Yi Ming Zhou, Keren Wang, Yiyang Zhao, Qingfeng Li, Zhanpin Qiao, Anguo Wu, Zhenghuai Tan, Wenmin Liu · 2021 · Bioorganic Chemistry
Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease
Anna Rubinski, Simon Frerich, Rainer Malik, Nicolai Franzmeier, Alfredo Ramı́rez, Martin Dichgans, Michael Ewers, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Annals of Neurology
An improved immobilized enzyme reactor-mass spectrometry-based label free assay for butyrylcholinesterase ligand screening
Adriana Ferreira Lopes Vilela, Cláudia Seidl, Juliana Maria Lima, Carmen Lúcia Cardoso · 2018 · Analytical Biochemistry
Should we move dementia research funding from a cure to its care?
Gloria Hoi Yan Wong, Martin Richard John Knapp · 2020 · Expert Review of Neurotherapeutics
Targeted screening for Alzheimer’s disease clinical trials using data-driven disease progression models
Oxtoby, Neil P., Shand, Cameron, Cash, David M., Alexander, Daniel C., Barkhof, Frederik · 2022 · Frontiers in Artificial Intelligence
Single molecule imaging of protein aggregation in Dementia: Methods, insights and prospects
John S. H. Danial, David Klenerman · 2021 · Neurobiology of Disease
Properties of odor identification testing in screening for early-stage Alzheimer’s disease
Eglė Audronytė, Gyte Pakulaite-Kazliene, Vaiva Sutnikiene, Gintaras Kaubrys · 2023 · Scientific Reports
MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease
Massimo Filippi, Giordano Cecchetti, Federica Agosta · 2023 · Current Opinion in Neurology
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Xinyue Li, Meina Quan, Yiping Wei, Wei Wang, Lingzhi Xu, Qi Wang, Jianping Jia · 2023 · Science China Life Sciences
Paradigm shift required for translational research on the brain
Jong Hyuk Yoon, Dongha Lee, Chany Lee, Eunji Cho, Seulah Lee, Amaury Cazenave‐Gassiot, Kipom Kim, Sehyun Chae, Edward A. Dennis, Pann‐Ghill Suh · 2024 · Experimental & Molecular Medicine
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
Lara Blömeke, Fabian Rehn, Marlene Pils, Victoria Kraemer‐Schulien, Anneliese Cousin, Janine Kutzsche, Tuyen Bujnicki, Silka Dawn Freiesleben, Luisa‐Sophie Schneider, Lukas Preis et al. · 2024 · Communications Medicine
Timely Detection of Mild Cognitive Impairment in Italy: An Expert Opinion
Angelo Bianchetti, Nicola Ferrara, Alessandro Padovani, Elio Angelo Scarpini, Marco Trabucchi, Stefania Maggi · 2019 · Journal of Alzheimer s Disease
Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?
Maureen Dumba, Sairah R. Khan, Neva Patel, Laura Perry, Paresh Malhotra, Richard J. Perry, Kuldip S. Nijran, Tara D. Barwick, Kathryn L. Wallitt, Zarni Win · 2019 · British Journal of Radiology
In silico identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitor
Mahesh Kumar Teli, Surendra Kumar, Dharmendra Kumar Yadav, Mi‐Hyun Kim · 2020 · Journal of Biomolecular Structure and Dynamics